Back

Long-term outcomes after renal denervation in the two defined ESC guideline-recommended patient groups: an analysis from the Global SYMPLICITY Registry DEFINE

31 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Renal denervation Device Treatment and Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Felix Mahfoud

University Hospital Basel, Basel (Switzerland)

7 More presentations in this session

Presentation thumbnail
Effect of catheter-based renal denervation on orthostatic blood pressure adaptations in patients with uncontrolled hypertension
Doctor Z. Zhang (Chengdu, CN)
Abstract Slides Video
Presentation thumbnail
Cost-effectiveness of RF RDN in ESC Hypertension guideline-recommended indications in six European countries: an analysis based on Global SYMPLICITY Registry DEFINE data
Professor R. Schmieder (Erlangen, DE)
Abstract Slides Video
Presentation thumbnail
Renal denervation in hypertensive patients with renal impairment: ultra-long-term follow-up study
Doctor L. Wang (Tianjin, CN)
Abstract Slides Video
Presentation thumbnail
Therapeutic effects of renal denervation beyond arterial hypertension, a systematic review and meta-analysis.
Mr A. Makris (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Early and sustained blood pressure control from discharge to 12 months after renal denervation: a time in therapeutic range analysis from a nationwide resistant hypertension registry
Doctor L. Wu (Hsinchu, TW)
Abstract Slides Video

Access the full session

Session thumbnail
Renal denervation

The Event

Event poster

ESC Congress 2025

31 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Opening: tackling the unmet need in hypertension care
thumbnail
Congress Presentation
State-of-the-art lecture on device-based hypertension management
thumbnail
Congress Presentation
Hot papers on device-based treatment of hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources